Agile Data Engine (ADE), provider of the all-in-one SaaS DataOps Development and Operations Platform for development, provision and operation of data lakehouses, has now been awarded Built on Partner status by Databricks, the Data and AI company.

Dubai Culture and Arts Authority (Dubai Culture) has launched the ‘Creative Dubai: Navigating Tomorrow’s Creative Landscape’ report developed in collaboration with DinarStandard, a privately owned growth strategy research and advisory firm empowering organisations for responsible global impact. The report highlights Dubai’s achievements in the cultural and creative industries, the key factors contributing to the city’s cultural vision, and significant data tracking the sector’s transformation.

Avanzanite Bioscience B.V., a leading commercial-stage specialty pharmaceutical company committed to bringing ground-breaking medicines for rare diseases to market, announced today the appointment of Jason Cameron as Chief Technical Officer (CTO). This move marks a significant step in Avanzanite’s mission to accelerate growth, expand its presence in Europe, and advance the company’s next phase of international partnerships and product launches.

illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Operating Officer (COO).

Jörg joined illumynt in June 2022 and has held several executive roles within the organization. In his new role Jörg will be focusing on solidifying illumynt's position as the market leader in IT Asset Disposition services for the AI and compute sector. He will also lead efforts to expand illumynt's global reverse supply chain solutions for OEMs.

Dfns, the leading wallet-as-a-service platform for crypto assets, has successfully closed a $16 million Series A, led by Further Ventures, the venture arm of Abu Dhabi’s largest sovereign wealth fund, ADQ. This round also saw participation from historic investors such as White Star Capital, Hashed, Semantic, Techstars, and Bpifrance, alongside new backers including Motive Partners, Wintermute, and Motier Ventures.

Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced the launch of the AWS Mexico (Central) Region. Starting today, developers, startups, entrepreneurs, and enterprises, as well as government, education, and nonprofit organizations, will have greater choice for running their applications and serving end users from AWS data centers located in Mexico. As part of its long-term commitment, AWS is planning to invest more than $5 billion in Mexico over 15 years.

Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global alternative investment manager, announced today the final closing of its sixth commingled European direct lending fund, Ares Capital Europe VI (“ACE VI” or the “Fund”). With total commitments of €17.1 billion, the Fund closed above its €15 billion target and reached its hard cap. Ares believes that ACE VI is the largest institutional fund in the global direct lending market to date based on LP equity commitments.

Adtran today announced the expansion of Alcorn County Electric Power Association’s (ACE Power) fiber subsidiary, ACE Fiber, into New Albany, Mississippi. The new network utilizes Adtran’s comprehensive suite of fiber network technologies, significantly enhancing internet speed, accessibility and reliability for homes and businesses throughout the city.

Esmark, Inc. and Esmark Steel Group today reaffirmed their support for the proposed merger between U.S. Steel and Nippon Steel and urges the Trump administration to revisit this alliance. The proposed merger is positioned to bring significant benefits to the combined company’s workers, strengthened U.S. national security, as well as bolstering America’s status in the international steel industry.

The Global Antibiotic Research & Development Partnership (GARDP) and the Swiss-based global biopharmaceutical company Debiopharm have signed a memorandum of understanding to develop Debio 1453, a novel compound representing a new antibiotic class that targets Neisseria gonorrhoeae. Multidrug-resistant strains of N. gonorrhoeae have emerged globally, limiting treatment options and elevating this pathogen to the high-priority category on the World Health Organization’s Bacterial Priority Pathogen List.